SCHEMBL2883784

SCHEMBL2883784

Cc1cc(S(C)(=O)=O)ccc1-c1ccc(OCC2CCN(C(=O)OCC(C)C)CC2)cn1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 17/20 0.51
GPR183 P32249 1/20 0.46
CYP4F2 P78329 3/20 0.45
CYP4A11 Q02928 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881163 0.91 GPR119 (0.52) GPR119GPR183CYP4F2CYP4A11
SCHEMBL388784 0.90 GPR119 (0.58) GPR119
SCHEMBL2881232 0.87 GPR119 (0.61) GPR119GPR183CYP4F2CYP4A11
SCHEMBL387364 0.86 GPR119 (0.56) GPR119
SCHEMBL3844766 0.86 CYP4F2 (0.46) GPR119CYP4F2CYP4A11
SCHEMBL2881607 0.84 GPR119 (0.58) GPR119GPR183CYP4F2CYP4A11
SCHEMBL387662 0.81 GPR119 (0.62) GPR119
SCHEMBL2881370 0.80 GPR119 (0.51) GPR119
SCHEMBL3844161 0.80 GPR119 (0.55) GPR119GPR183
SCHEMBL2881337 0.80 GPR119 (0.56) GPR119GPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010512334-A 2010-04-22 JP claimed
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP claimed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO claimed
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP disclosed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO disclosed